Gallopamil
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | C08DA02 (WHO) |
| Identifiers | |
| |
| CAS Number |
16662-46-7 16662-47-8 |
| PubChem (CID) | 1234 |
| ChemSpider |
1197 |
| UNII |
39WPC8JHR8 |
| KEGG |
D01969 |
| ChEMBL |
CHEMBL51149 |
| ECHA InfoCard | 100.036.989 |
| Chemical and physical data | |
| Formula | C28H40N2O5 |
| Molar mass | 484.62 g/mol |
| 3D model (Jmol) | Interactive image |
| Chirality | Racemic mixture |
| |
| |
| | |
Gallopamil (INN) is a L-type calcium channel blocker, that is an analog of verapamil. It is used in the treatment of cardiac arrhythmias.[1]
References
- ↑ Sewing K-F, Hannemann H (1983). "Calcium Channel Antagonists Verapamil and Gallopamil Are Powerful Inhibitors of Acid Secretion in Isolated and Enriched Guinea Pig Parietal Cells". Pharmacology. 27: 9–14. doi:10.1159/000137824.
This article is issued from Wikipedia - version of the 9/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
-Gallopamil_Structural_Formula_V.1.svg.png)